Plasma half-life of cytosine arabinoside in patients with leukaemia—the effect of uridine
- 31 January 1975
- journal article
- Published by Elsevier
- Vol. 11 (1) , 43-49
- https://doi.org/10.1016/0014-2964(75)90036-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The separation of different cell classes from lymphoid organs. V. Simple procedures for the removal of cell debris, damaged cells and erythroid cells from lymphoid cell suspensionsJournal of Immunological Methods, 1972
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Studies of the enzymatic deamination of ara-cytidine—V: Inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosidesBiochemical Pharmacology, 1968
- Studies of the enzymatic deamination of ara-cytidine—IVBiochemical Pharmacology, 1968
- Studies of the enzymatic deamination of cytosine arabinoside—IIIBiochemical Pharmacology, 1967
- Clinical pharmacology and human antitumor activity of cytosine arabinosideCancer, 1967
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965
- Hereditary Orotic Aciduria and Megaloblastic Anaemia: A Second Case, with Response to UridineBMJ, 1965
- A proposed mechanism of action of 1-β-d-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cellsBiochemical Pharmacology, 1962